Limited spaces available
7:00-7:45 am
Registration and breakfast @Exhibit Hall
7:45-8:00 am
Welcoming remarks
Héctor J. Martínez, MD, FACC / Governor ACC-PR chapter
Karen Rodríguez, MD, FACC / President Scientific Committee
8:00-10:20 am – SESSION 1
8:00-8:20 am
Covid-19 and cardiovascular disease: what we know in 2021
Richard Kovacs, MD
8:20-8:40 am
Recommendations in primary ASCVD risk assessment that clinician should know
Salim Virani, MD
8:40-9:00 am
Recommendations in secondary ASCVD risk assessment that clinician
should know
Salim Virani, MD
9:00-9:20 am
Role of Cardiac CT in CAD evaluation
Camila Saadé Yordán, MD
9:20-9:40 am
Case discussions in cholesterol management base on 2018 ACC/AHA guidelines
Salim Virani, MD
9:40-9:50 am
Q & A Speaker Panel
9:50-10:20 am
Coffee break @Exhibit Hall
10:20-12:00 pm SESSION 2
10:20-10:40 am
Thoracoabdominal aneurysm repair hybrid, endovascular or open repair when is the best choice?
Vicente Orozco Sevilla, MD
10:40-11:00 am
TAVR for Aortic, Regurgitation: Are we there yet?
Susheel K. Kodali, MD
11:00-11:20 am
Clinical outcomes in aortic stenosis with coronary microvascular dysfunction
Sharmila Dorbala, MD
11:20-11:30 am
Q & A Speaker Panel
11:30-12:00 pm
Moderator: Orlando Rodriguez Vila, MD
CTO Case Selection: Appropriateness and Techniques
Ricardo Santiago, MD & Hector Martínez, MD
12:00-1:30 pm
Lunch Symposium
1:30-2:10 pm SESSION 3
1:30-1:40 pm
Implementing a pharmacogenetic driven algorithm to guide dual antiplatelet therapy in Caribbean Hispanics: protocol for a nonrandomized clinical trial
Héctor Núñez, MD
1:40-1:50 pm
Management of post TAVR perivalvular leak
Melanie Quintana, MD
1:50-2:00 pm
Unusual cause of heart failure
Fermin López, MD
2:00-2:10 pm
Q & A Speaker Panel
2:10-3:30 pm SESSION 4
2:10-2:30 pm
Interventional Atrial fibrillation management: What’s Next
Fred Kusumoto, MD
2:30-2:50 pm
ECG and device tracing analysis: What is the diagnosis?
Helder Hernández, MD
2:50-3:10 pm
Atrial Fibrillation screening: Will wearables, AI and other new tools help?
Fred Kusumoto, MD
3:10-3:20 pm
Protecting the heart of the athlete in 2021
Richard Kovacs, MD
3:20-3:30 pm
Q & A Speaker Panel
3:30-3:50 pm
Coffee break @Exhibit Hall
3:50-5:00 pm SESSION 5
3:50-4:10 pm
Highlights: Expert consensus recommendations for multimodality imaging
in cardiac amyloidosis
Sharmila Dorbala, MD
4:10-4:30 pm
Cardiac device therapy: New options and new indications?
Fred Kusumoto, MD
4:30-4:50 pm
Nuclear imaging for cardiac amyloidosis: 99 m Tc-PYP scan & ongoing
investigations to detect AL vs ATTR
Sharmila Dorbala, MD
4:50-5:00 pm
Q & A Speaker Panel
5:00 pm
Closing remarks
7:00-7:45 am
Registration and breakfast @Exhibit Hall
7:45-8:00 am
Welcoming remarks
Héctor J. Martínez, MD, FACC / Governor ACC-PR chapter
Karen Rodríguez, MD, FACC / President Scientific Committee
8:00-9:50 am SESSION 6
8:00-8:20 am
Evaluation of native aortic valve stenosis: Multimodality Cardiac Imaging Assessment of severity
Omar Khalique, MD
8:20-8:40 am
Bioprosthetic valve leaflet thrombosis: incidence, management, and other considerations!
Susheel K. Kodali, MD
8:40-9:00 am
Multimodality Cardiac Imaging evaluation of prosthetic surgical and transcatheter aortic valve function
Omar Khalique, MD
9:00-9:20 am
Coronary access post TAVR: implantation techniques to support future access
Susheel K. Kodali, MD
9:20-9:40 am
TAVR: Multidisciplinary team approach management of small aortic annulus
Vicente Orozco Sevilla, MD
9:40-9:50 am
Q & A Speaker Panel
9:50-10:20 am
Coffee break @Exhibit Hall
10:20-12:00 SESSION 7
10:20-10:40 am
Rationale for revascularization in SIHD
Ajay J. Kirtane, MD
10:40-11:00 am
How to improve higher-risk PCI?
Ajay J. Kirtane, MD
11:00- 11:20 am
Management of coronary artery disease in the post ischemia trial era
Vicente Orozco Sevilla, MD
11:20-11:30 pm
Q & A Speaker Panel
11:30-12:00 pm
Moderator: Miguel Campos, MD
TAVR: Essentials and Controversies
Edwin Pérez, MD & Alejandro López, MD
12:00-1:30 pm
Lunch Symposium
1:30-2:20 pm SESSION 8
1:30-2:00 pm
Master Lecture: Dr. José E. López Rodríguez
Cardiology challenges in the next decade
Athena Poppas, MD
2:00-2:20 pm
State of the chapter and Presidential Address
Héctor Martínez Gonzalez, MD & Athena Poppas, MD
2:20-3:00 pm SESSION 9
2:20-2:30 pm
Carney complex: The complex of cardiac myxoma
Edwin Molina, MD
2:30-2:40 pm
An uncommon human pathogen causing infective endocarditis in TAVR
Sergio Alegre, MD
2:40-2:50 pm
Ebstein’s Anomaly and Eosinophilic Cardiomyopathy: A Rare Dire Combination
Andrés Córdova, MD
2:50-3:00 pm
Q & A Speaker Panel
3:00-4:10 pm SESSION 10
3:00-3:20 pm
Multimodality cardiovascular imaging evaluation: concomitant mitral valve disease & aortic stenosis in TAVR era
Omar Khalique, MD
3:20-3:40 pm
Percutaneous mitral valve replacement
Paul Sorajja, MD
3:40-4:00 pm
Sutureless rapid deployment valves instead of abdominal aorta repair
Vicente Orozco Sevilla, MD
4:00-4:10 pm
Q & A Speaker Panel
4:10-4:20 pm
Coffee break @Exhibit Hall
4:20-5:00 pm SESSION 11
4:20-4:40 pm
Don’t forget tricuspid valve: transcatheter therapeutic options
Paul Sorajja, MD
4:40-5:00 pm
Renal denevation therapies for hypertension
Ajay J. Kirtane, MD
5:00 – 5:20pm
Q & A Speakers Panel
5:20pm
Closing remark
*Program subject to change
Sharmila Dorbola,MD
Director, Nuclear Cardiology
Brigham and Women’s Hospital
Professor, Radiology
Harvard Medical School
Past President, American Society of Nuclear Cardiology
Boston, MA
Omar Khalique, MD
Associate Professor of Medicine (Radiology)
The Columbia University Medical Center
Director
Multimodality Cardiac Imaging
The Columbia Structural Heart & Valve Center
New York Presbyterian Hospital/Columbia University Irving Medical Center
Co-director
Structural Heart Imaging Fellowship
Director
Structural CT core lab at the Cardiovascular Research Foundation
New York, NY
Ajay J. Kirtane, MD, SM, FACC
Professor of Medicine
Columbia University Irving Medical Center
Director of the Cardiac Catheterization Laboratories
New York-Presbyterian/Columbia University Irving Medical Center
New York, NY
Susheel K. Kodali, MD, FACC
Director, Structural Heart & Valve Center
New York-Presbyterian/Columbia University Medical Center. D
Director, Interventional Cardiology Fellowship Program
Associate Professor in Medicine
Columbia University Irving Medical Center
New York, NY
Richard Kovacs, MD, FACC
ACC CMA / CMO
Past President American College of Cardiology
Q. E. and Sally Russell
Professor of Cardiology
Professor of Clinical Medicine
Clinical Director, Krannert Institute of Cardiology
Indiana University School of Medicine
Indianapolis, IN
Fred Kusomoto, MD, FACC
2021 President of Heart Rhythm Society
Director
Heart Rhythm Services
Mayo Clinic
Jacksonville, FL
Vicente Orozco Sevilla, MD
Assistant Professor of Surgery
Division of Cardiothoracic Surgery
Baylor College of Medicine
Houston, TX
Athena Poppas, MD, FACC
Immediate Past President American College of Cardiology
Professor of Medicine
Brown Medical School
Director, Echocardiography Laboratory
Rhode Island Hospital
East Providence, RI
Paul Sorajja, MD, FACC
Roger L. and Lynn C. Headrick Family Chair
Valve Science Center, Minneapolis Heart Institute Foundation
Director, Center for Valve and Structural Heart Disease
Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, MN
Salim Virani, MD, FACC
Professor in Cardiology and Cardiovascular Research Sections
Investigator in the Health Policy, Quality, and Informatics Program
Michael E. DeBakey VA HSR&D Center of Innovation
Director for the Cardiovascular Disease Fellowship
Baylor College of Medicine
Houston, TX
The Puerto Rico Chapter of the American College of Cardiology, on its 31st Meeting, will provide the most updated information regarding the management of basic and complex cardiovascular diseases and practice improvement. Considering that valvular heart disease (VHD) is a common condition we have chosen to explore this topic in detail. Near 5 million individuals are diagnosed with VHD, amongst those aortic and mitral valve stenosis and insufficiency the most common and devastating. Close to 500,000 patients have aortic valve disease and half of those are symptomatic. Without a valve, half those patients will die within 2 or 3 years, underscoring the relevance of this variate disease presents. A well-balanced scientific program has been developed, emphasizing appropriateness of care in patients with progressive and severe valvular disease and other relevant conditions carrying significant morbidity and mortality in our population. Also, will highlight the application of current guidelines, existing and new technologies, and breakthroughs in the management and prevention of cardiovascular diseases.
Objectives for the 2021 ACC PR Chapter Scientific Meeting
Sponsorship Statement
This activity is sponsored by The Ponce Medical School Foundation, Inc. and the American College of Cardiology Puerto Rico Chapter.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Ponce Medical School Foundation, Inc and the American College of Cardiology Puerto Rico Chapter. The Ponce Medical School Foundation, Inc is accredited by the Accreditation Council for Continuing Medical Education (ACCME), Provider’s No. 0007249, to provide continuing medical education for physicians. The Ponce Medical School Foundation, Inc is accredited by the Puerto Rico Board of Licensing and Medical Disciplines, provider’s No. 016-DC23-JLDM.
Credit Designation
The Ponce Medical School Foundation, Inc designates this educational activity for a maximum of 15.5 AMA PRA Category 1 Credits™ subject to approval. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
It is the policy of Ponce Medical School Foundation, Inc to ensure independence, balance, objectivity, scientific rigor and integrity in all of its sponsored educational activities.
All persons who are in a position to control the educational content of a sponsored activity are expected to disclose to the participants any relevant financial relationship(s) they and/or spouse/partner have with the commercial supporters and/or providers of commercial services and/or manufacturers of any commercial products discussed during the educational activity. All conflicts of interest have been identified and resolved prior to the release of this activity.
The faculty will report financial relationships or relationships to products or devices they or their spouse/partner have with commercial interests related to the content of this CME activity.
Target Audience
This CME activity has been designed for Physicians.
FREE
Until Monday November 8, 2021 add $50.00 of penalty. After this date there is no refund of money.
Convention Room Rate – $185.00 + taxes in single or double occupancy
Contact Reservation at (787) 721-0303
Group Code: ACCP21